Dr. Elan Cohen is a PI at Hassman Research Institute with ample experience in rater training and data surveillance. He is also significantly engaged in research exploring various interventions aimed at systemically reducing the insidious placebo and nocebo effects within clinical trials (http://www.hritrials.com/hri-science-division-2/). Dr. Cohen conducted two separate presentations to attendees from each Alliance site…

Thanks to all who participated in our recent webinar, “Driving Impairment: Avoiding Roadblocks in Drug Development.” If you missed it, a recording of the presentation is available. If you have a compound in development that has potential to impair driving ability, this is necessary information. Attending DIA or ASCP? Don’t miss the chance to experience…